Пламенный насос. Естественная история сердца

¹³⁴ R.S. Litwak, “The Growth of Cardiac Surgery: Historical Notes,” Cardiovascular Clinics 3 (1971): 5–50.

¹³⁵ H.W. Heiss, “Werner Forssmann: A German Problem with the Nobel Prize,” Clinical Cardiology 15 (1992): 547–549.

¹³⁶ Heiss, “Werner Forssmann.”

¹³⁷ “Shoe-Fitting Fluoroscope (ca. 1930–1940),” Oak Ridge Associated Universities, 1999, https://www.orau.org/ptp/collection/shoefittingfluor/shoe.htm.

¹³⁸ Werner Forssmann, Experiments on Myself: Memoirs of a Surgeon in Germany, trans. H. Davies (New York; St. Martin’s Press, 1974): 84.

¹³⁹ Ahmadreza Afshar, David P. Steensma, and Robert A. Kyle, “Werner Forssmann: A Pioneer of Interventional Cardiology and Auto-Experimentation,” Mayo Clinic Proceedings 93, no. 9 (September 1, 2018): E97–98.

¹⁴⁰ K. Agrawal, “The First Catheterization,” Hospitalist 2006, no. 12 (December 2006).

¹⁴¹ Forssmann, Experiments on Myself, xi.

¹⁴² Lisa-Marie Packy, Matthis Krischel, and Dominik Gross, “Werner Forssmann – A Nobel Prize Winner and His Political Attitude Before and After 1945,” Urologia Internationalis 96, no. 4 (2016): 379–385.

¹⁴³ Afshar, Steensma, and Kyle, “Werner Forssmann.”

¹⁴⁴ Packy, Krischel, and Gross, “Werner Forssmann,” 383.

¹⁴⁵ Jessica Yi Han Aw, Vasoontara Sbirakos Yiengprugsawan, and Cathy Honge Gong, “Utilization of Traditional Chinese Medicine Practitioners in Later Life in Mainland China,” Geriatrics (Basel) 4, no. 3 (September 2019): 49.

¹⁴⁶ Gert-Jan Lokhorst, “Descartes and the Pineal Gland,” Stanford Encyclopedia of Philosophy, 2013, https://plato.stanford.edu/entries/pineal-gland/.

¹⁴⁷ Lokhorst, “Pineal Gland.”

¹⁴⁸ Fay Bound Alberti, Matters of the Heart: History, Medicine and Emotion (Oxford: Oxford University Press, 2010), 2.

¹⁴⁹ John C. Hellson, “Ethnobotany of the Blackfoot Indians, Ottawa,” National Museums of Canada, Mercury Series, 60, Native American Ethnobotany DB, http://naeb.brit.org/uses/31593/.

¹⁵⁰ Jennifer Worden, “Circulatory Problems,” Homeopathy UK, https://homeop-athy-uk.org/homeopathy/how-homeopathy-helps/conditions/circulatory-problems.

¹⁵¹ Takeo Sato et al., “Takotsubo (Ampulla-Shaped) Cardiomyopathy Associated with Microscopic Polyangiitis,” Internal Medicine 44, no. 3 (2005): 251–255.

¹⁵² Alexander R. Lyon et al., “Current State of Knowledge on Takotsubo Syndrome: A Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology,” European Journal of Heart Failure 18, no. 1 (January 2016): 8–27.

¹⁵³ R.P. Sloan, E. Bagiella, and T. Powell, “Religion, Spirituality, and Medicine,” Lancet 353, no. 9153 (February 20, 1999).

¹⁵⁴ “What Is Mindfulness?” Greater Good Magazine, https://greatergood.berke-ley.edu/topic/mindfulness/definition.

¹⁵⁵ Quinn R. Pack et al., “Participation in Cardiac Rehabilitation and Survival After Coronary Artery Bypass Graft Surgery: A Community-Based Study,” Circulation 128, no. 6 (August 6, 2013): 590–597.

¹⁵⁶ Shannon M. Dunlay et al., “Participation in Cardiac Rehabilitation, Readmissions, and Death after Acute Myocardial Infarction,” American Journal of Medicine 127, no 6 (June 2014): 538–546.

¹⁵⁷ Shannon M. Dunlay et al., “Barriers to Participation in Cardiac Rehabilitation,” American Heart Journal 158, no. 5 (November 2009): 852–859.

¹⁵⁸ “Keeping Proportions in Proportion,” November 2007, Harvard Health Publishing, Harvard Medical School, https://www.health.harvard.edu/newslet-ter_article/Keeping_portions_in_proportion.

¹⁵⁹ Hannah Ritchie and Max Roser, “Meat and Dairy Production,” November 2019, Our World in Data, https://ourworldindata.org/meat-production.

¹⁶⁰ A. Strom and R.A. Jensen, “Mortality from Circulatory Diseases in Norway 1940–1945,” Lancet 1, no. 6647 (January 20, 1951): 126–129.

¹⁶¹ Jason A. Cook et al, “The Total Artifi cial Heart,” Journal of Thoracic Disease 7, no. 12 (December 2015): 2172–2180.

¹⁶² Ibadete Bytyçi and Gani Bajraktari, “Mortality in Heart Failure Patients,” Anatolian Journal of Cardiology 15, no. 1 (January 2015): 63–68.

¹⁶³ “Why Use the Zebrafi sh in Research?” YourGenome, 2014, https://www.yourgenome.org/facts/why-use-the-zebrafish-in-research.

¹⁶⁴ David I. Bassett and Peter D. Curry, “The Zebrafi sh as a Model for Muscular Dystrophy and Congenital Myopathy,” Supplement, Human Molecular Genetics 12, no. S2 (October 15, 2003): R265–70.

¹⁶⁵ Federico Tessadori et al., “Effective CRISPR/Cas9-Based Nucleotide Editing in Zebrafi sh to Model Human Genetic Cardiovascular Disorders,” Disease Models & Mechanisms 11 (2018), https://dmm.biologists.org/content/11/10/dmm035469#abstract-1.

¹⁶⁶ Kenneth D. Poss, Lindsay G. Wilson, and Mark T. Keating, “Heart Regeneration in Zebrafi sh,” Science 298, no. 5601 (December 13, 2002): 2188–2190.

¹⁶⁷ Angel Raya et al., “Activation of Notch Signaling Pathway Precedes Heart Regeneration in Zebrafi sh, Supplement,” Proceedings of the National Academy of Sciences 100, no. S1 (2003): 11889–95.